News Willow Biosciences Inc.

Equities

WLLW

CA97111B4047

End-of-day quote Toronto S.E. Other stock markets 06:00:00 2024-06-04 pm EDT			5-day change	1st Jan Change
0.11 ^CAD	0.00%		+29.41%	+10.00%

Jun. 03	Willow Biosciences to Raise Up to $3 Million Via Brokered Private Placement; Shares Jumped 24% on Friday	MT
Jun. 03	Willow Biosciences Brief: Announcing Brokered Private Placement Offering To Raise Up To $3 Million	MT

Summary

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Willow Biosciences to Raise Up to $3 Million Via Brokered Private Placement; Shares Jumped 24% on Friday	Jun. 03	MT
Willow Biosciences Brief: Announcing Brokered Private Placement Offering To Raise Up To $3 Million	Jun. 03	MT
WILLOW ANNOUNCES BROKERED PRIVATE PLACEMENT OFFERING TO RAISE UP TO $3.0 MILLION	Jun. 03	AQ
Willow Biosciences Inc. announced that it expects to receive CAD 3 million in funding	Jun. 02	CI
Willow Biosciences Signs Multi-Product Development, Licensing Partnership With Laurus Lab	May. 30	MT
Willow Biosciences Brief: Announcing Multi-product Development and Licensing Partnership With Laurus Lab	May. 30	MT
Willow Biosciences Inc. Announces Multi-Product Development and Licensing Partnership with Laurus Labs	May. 30	CI
WILLOW ANNOUNCES MULTI-PRODUCT DEVELOPMENT AND LICENSING PARTNERSHIP WITH LAURUS LABS FOR MANUFACTURING ACTIVE PHARMACEUTICAL INGREDIENTS	May. 30	AQ
Willow Biosciences Brief: Reiterating its Expectations of at least doubling its full year 2024 revenues, As Reports Q1 Results	May. 13	MT
Willow Biosciences Inc. Provides Earnings Guidance for the Fiscal Year 2024	May. 13	CI
Willow Biosciences Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	May. 13	CI
Willow Biosciences Narrows 2023 Loss YOY	Apr. 01	MT
Willow Biosciences Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 29	CI
WILLOW BIOSCIENCES REPORTS FOURTH QUARTER AND FISCAL YEAR 2023 FINANCIALS AND OPERATIONS AND FILING OF ITS 2023 AIF	Mar. 28	AQ
Willow Biosciences Announces Second Strategic Investment From Kalsec	Mar. 01	MT
Willow Biosciences Secures Strategic Investment From Kalsec to Develop Natural Food Ingredient	Feb. 21	MT
Willow Biosciences Inc. announced that it expects to receive funding from Kalsec Inc.	Feb. 19	CI
Willow Biosciences Enters Partnership With Global Ingredient Manufacturer	Jan. 31	MT
Willow Biosciences Inc. Announces Collaboration with Global Active Pharmaceutical Ingredient Manufacturer to Develop A More Sustainable, Cost-Effective Manufacturing Process for A Large Volume Global Market	Jan. 31	CI
WILLOW ANNOUNCES COLLABORATION WITH GLOBAL INGREDIENT MANUFACTURER TO DEVELOP A MORE COST-EFFECTIVE, SUSTAINABLE PROCESS FOR A LARGE VOLUME ACTIVE PHARMACEUTICAL INGREDIENT	Jan. 31	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Willow Biosciences Inc.

Equities

WLLW

CA97111B4047

Summary

Filters